Page 76 - FBL AR 2019-20

Fermenta Biotech Limited
Annual Report 2019-20

Annexure II
Form AOC-I
(Pursuant to first proviso to sub-section (3) of section 129 read with rule 5 of Companies (Accounts) Rules, 2014)
Statement containing salient features of the financial statement of subsidiaries/associate companies/joint venture entities

Part “A”: Subsidiaries
Sl. Particulars (H In Lakhs)
No.
1. Name of the subsidiary: Fermenta Biotech Aegean Properties CC Square Films G I Biotech Private Fermenta Biotech
GmbH Limited Limited Limited (UK) Limited
2. The date since when subsidiary 05.09.2019 01.02.2002 10.01.2011 25.08.2004 10.09.2002
was acquired
3. Reporting period for the - - - - -
subsidiary concerned, if
different from the holding
company’s reporting period
4. Reporting currency and Euro € INR INR INR Pound Sterling £
Exchange rate as on the last (Exchange Rate: (Exchange Rate:
date of the relevant Financial 1 Euro = 83.04 1 GBP = 93.07
year in the case of foreign INR for INR for
subsidiaries Assets, 83.21 INR Assets, 93.26 INR
for Liabilities, for Liabilities,
and 1 Euro = and 1 GBP = 92.57
79.72 INR for Profit
INR for Profit and Loss account
and Loss account as
as on 31.03.2020)
on 31.03.2020)
5. Share capital 19.33 30.00 5.00 1.00 183.59
6. Reserves & surplus (232.17) 101.22 (5.00) 2.39 (148.43)
7. Total assets 2290.32 142.52 - 3.89 37.66
8. Total Liabilities 2503.17 11.30 - 0.50 2.50
9. Investments - - - - -
10. Turnover 84.62 18.00 0.02 - 1.09
11. Profit before taxation (223.85) 9.80 (0.002) (1.10) (0.18)
12. Provision for taxation - 2.47 - (0.10) -
13. Profit after taxation (223.85) 7.33 (0.002) (1.00) (0.18)
14. Proposed Dividend - - - - -
15. % of shareholding 100% 100% 100% 62.50% 100%

74